Results 101 to 110 of about 12,288,625 (151)

Targeting the Myocardial Microenvironment: Novel Antiviral Strategies and Therapeutic Perspectives for Coxsackievirus B-Induced Myocarditis. [PDF]

J Am Heart Assoc
Yue Y, Wei C, Ding M, Zhang X, Li X, Liu L, Liu C, Wang C.   +7 more
europepmc   +1 more source

A hexavalent Coxsackievirus B vaccine is highly immunogenic and has a strong protective capacity in mice and nonhuman primates. [PDF]

Sci Adv, 2020
Stone VM, Hankaniemi MM, Laitinen OH, Sioofy-Khojine AB, Lin A, Diaz Lozano IM, Mazur MA, Marjomäki V, Loré K, Hyöty H, Hytönen VP, Flodström-Tullberg M.   +11 more
europepmc   +1 more source

MiR-146a down-regulates inflammatory response by targeting TLR3 and TRAF6 in Coxsackievirus B infection. [PDF]

RNA, 2020
Fei Y, Chaulagain A, Wang T, Chen Y, Liu J, Yi M, Wang Y, Huang Y, Lin L, Chen S, Xu W, Tong L, Wu X, Zhao D, Zhang F, Zhao W, Zhong Z.   +16 more
europepmc   +1 more source

Coxsackievirus B escapes antiviral CD8⁺ T cells but triggers robust CD4⁺ memory responses. [PDF]

Sci Adv
Burgos-Morales O, Vecchio F, Samassa F, Petit M, Zhou Z, Brandao B, Carré A, Nicastri A, Dotsenko V, Shepherd C, Viiri K, Parker R, Linnemann AK, You S, Flodstrom-Tullberg M, Ternette N, Mallone R.   +16 more
europepmc   +1 more source

Notes: George B. Lincoln, October 14, 1890

, 1890
Note about an article in the New York Tribune writing about letter written by George B ...
Lincoln, George B.
core  

Eukaryotic translation elongation factor 1 alpha 1 facilitates coxsackievirus B replication through interacting with PABP, viral protein 3 CD and viral RNA. [PDF]

Virulence
Zhao S, Dong Y, Wang Y, Yang H, Luan T, He Y, Lin L, Chen Y, Fei Y, Wang G, Wang Y, Zhong Z, Qi N, Zhao W.   +13 more
europepmc   +1 more source

Interaction with Coxsackievirus and Adenovirus Receptor, but Not with Decay-Accelerating Factor (DAF), Induces A-Particle Formation in a DAF-Binding Coxsackievirus B3 Isolate

, 2004
Although many coxsackie B viruses interact with decay accelerating factor (DAF), attachment to DAF by itself is not sufficient to initiate infection.
J. Charles Whitbeck, Jeffrey M. Bergelson   +1 more
core  

In Vivo and In Vitro Studies Assessing the Antiviral Efficacy of Double Combinations Against Coxsackievirus B Infection. [PDF]

Microorganisms
Stoyanova A, Galabov S, Makarov V, Galabov AS.   +3 more
europepmc   +1 more source

Coxsackievirus B Type 4 Infection in β Cells Downregulates the Chaperone Prefoldin URI to Induce a MODY4-like Diabetes via <i>Pdx1</i> Silencing. [PDF]

Cell Rep Med, 2020
Bernard H, Teijeiro A, Chaves-Pérez A, Perna C, Satish B, Novials A, Wang JP, Djouder N.   +7 more
europepmc   +1 more source

TRIM56 restricts Coxsackievirus B infection by mediating the ubiquitination of viral RNA-dependent RNA polymerase 3D. [PDF]

PLoS Pathog
Wang Y, Dong Y, Luan T, Chen Y, Lin L, Li S, Feng D, Wei J, Fei Y, Wang G, Pan J, Wang Y, Zhong Z, Zhao W.   +13 more
europepmc   +1 more source